Page 19 - Read Online
P. 19

Pecoraro et al. Mini-invasive Surg 2024;8:29  https://dx.doi.org/10.20517/2574-1225.2023.90  Page 9 of 11

               Financial support and sponsorship
               None.


               Conflicts of interest
               Both authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2024.


               REFERENCES
               1.       Patel AR, Lee BH, Campbell SC, Zhou M, Fergany AF. Bilateral synchronous sporadic renal tumors: pathologic concordance and
                   clinical implications. Urology 2011;78:1095-9.  DOI  PubMed
               2.       Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation: experience
                   from treating 243 small renal masses over 7.5 years. Cancer 2010;116:3135-42.  DOI  PubMed
               3.       Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment
                   effect. J Natl Cancer Inst 2006;98:1331-4.  DOI  PubMed
               4.       Wang B, Gong H, Zhang X, et al. Bilateral synchronous sporadic renal cell carcinoma: retroperitoneoscopic strategies and intermediate
                   outcomes of 60 patients. PLoS One 2016;11:e0154578.  DOI  PubMed  PMC
               5.       Qi N, Li T, Ning X, Peng X, Cai L, Gong K. Clinicopathologic features and prognosis of sporadic bilateral renal cell carcinoma: a
                   series of 148 cases. Clin Genitourin Cancer 2017;15:618-24.  DOI  PubMed
               6.       Pahernik S, Cudovic D, Roos F, Melchior SW, Thüroff JW. Bilateral synchronous sporadic renal cell carcinoma: surgical
                   management, oncological and functional outcomes. BJU Int 2007;100:26-9.  DOI  PubMed
               7.       Jacobs BL, Gibbons EP, Gayed BA, Whetstone JL, Hrebinko RL. Management of bilateral synchronous renal cell carcinoma in a
                   single versus staged procedure. Can J Urol 2009;16:4507-11.  PubMed
               8.       Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology guidelines on renal cell carcinoma: the 2022 update.
                   Eur Urol 2022;82:399-410.  DOI  PubMed
               9.       Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: AUA guideline. J Urol 2017;198:520-9.  DOI  PubMed
               10.      Blute ML, Itano NB, Cheville JC, Weaver AL, Lohse CM, Zincke H. The effect of bilaterality, pathological features and surgical
                   outcome in nonhereditary renal cell carcinoma. J Urol 2003;169:1276-81.  DOI  PubMed
               11.      Paterson C, Yew-Fung C, Sweeney C, Szewczyk-Bieda M, Lang S, Nabi G. Predictors of growth kinetics and outcomes in small renal
                   masses (SRM ≤ 4 cm in size): Tayside active surveillance cohort (TASC) study. Eur J Surg Oncol 2017;43:1589-97.  DOI  PubMed
               12.      Sheikh NA, Khan MH, Pillai S, Lang S, Nabi G. Outcomes of synchronous and metachronous bilateral small renal masses (< 4 cm): a
                   population-based cohort study. Int Urol Nephrol 2018;50:657-63.  DOI  PubMed
               13.      Campi R, Muselaers S, Bertolo R, et al; EAU Young Academic Urologists (YAU) Renal Cancer Working Group. Selecting the best
                   candidates for non-surgical management of localized renal masses: the Occam’s razor. Minerva Urol Nephrol 2022;74:368-71.  DOI
                   PubMed
               14.      Bertolo R, Amparore D, Diana P, et al; EAU Young Academic Urologists (YAU) Renal Cancer working group. Cryoablation of small
                   renal masses in patients with solitary kidneys: worth crossing the road for? Minerva Urol Nephrol 2022;74:794-8.  DOI  PubMed
               15.      Marchioni M, Amparore D, Ingels A, et al; European Association of Urology (EAU) Young Academic Urologists (YAU) Renal
                   Cancer Working Group. Renal tumors ablation. Minerva Urol Nephrol 2021;73:549-51.  DOI  PubMed
               16.      Shuch B, Singer EA, Bratslavsky G. The surgical approach to multifocal renal cancers: hereditary syndromes, ipsilateral multifocality,
                   and bilateral tumors. Urol Clin North Am 2012;39:133-48, v.  DOI  PubMed
               17.      Johnson BA, Kim S, Steinberg RL, de Leon AD, Pedrosa I, Cadeddu JA. Diagnostic performance of prospectively assigned clear cell
                   likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging. Urol Oncol 2019;37:941-6.  DOI
                   PubMed  PMC
               18.      Steinberg RL, Rasmussen RG, Johnson BA, et al. Prospective performance of clear cell likelihood scores (ccLS) in renal masses
                   evaluated with multiparametric magnetic resonance imaging. Eur Radiol 2021;31:314-24.  DOI  PubMed  PMC
               19.      Wilson MP, Katlariwala P, Murad MH, Abele J, McInnes MDF, Low G. Diagnostic accuracy of 99mTc-sestamibi SPECT/CT for
                   detecting renal oncocytomas and other benign renal lesions: a systematic review and meta-analysis. Abdom Radiol 2020;45:2532-41.
                   DOI  PubMed
   14   15   16   17   18   19   20   21   22   23   24